4/5
01:34 pm
rprx
Assessing Royalty Pharma (RPRX) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]
Low
Report
Assessing Royalty Pharma (RPRX) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]
4/3
12:26 pm
rprx
1 Value Stock for Long-Term Investors and 2 Facing Challenges [Yahoo! Finance]
Low
Report
1 Value Stock for Long-Term Investors and 2 Facing Challenges [Yahoo! Finance]
4/1
09:48 pm
rprx
Royalty Pharma, Johnson & Johnson Strike $500M Autoimmune Drug Deal [Yahoo! Finance]
Low
Report
Royalty Pharma, Johnson & Johnson Strike $500M Autoimmune Drug Deal [Yahoo! Finance]
3/31
08:33 am
rprx
1 Cash-Producing Stock to Own for Decades and 2 That Underwhelm [Yahoo! Finance]
Medium
Report
1 Cash-Producing Stock to Own for Decades and 2 That Underwhelm [Yahoo! Finance]
3/30
09:26 am
rprx
Royalty Pharma and J&J partner to develop autoimmune treatment [Yahoo! Finance]
Low
Report
Royalty Pharma and J&J partner to develop autoimmune treatment [Yahoo! Finance]
3/30
07:15 am
rprx
Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases
Low
Report
Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases
3/27
09:42 am
rprx
Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update [Yahoo! Finance]
Low
Report
Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update [Yahoo! Finance]
3/23
07:15 am
rprx
Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence
Low
Report
Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence
3/21
05:24 pm
rprx
How The Royalty Pharma (RPRX) Story Is Shifting With New Deals And Updated Expectations [Yahoo! Finance]
Low
Report
How The Royalty Pharma (RPRX) Story Is Shifting With New Deals And Updated Expectations [Yahoo! Finance]
3/17
04:43 pm
rprx
Royalty Pharma Announces Expansion of Leadership Team [Yahoo! Finance]
Low
Report
Royalty Pharma Announces Expansion of Leadership Team [Yahoo! Finance]
3/17
04:01 pm
rprx
Royalty Pharma Announces Expansion of Leadership Team
Low
Report
Royalty Pharma Announces Expansion of Leadership Team
3/3
07:33 pm
rprx
Royalty Pharma plc (RPRX) Earns $51 Target as 2026 Growth Outlook Exceeds Expectations [Yahoo! Finance]
Low
Report
Royalty Pharma plc (RPRX) Earns $51 Target as 2026 Growth Outlook Exceeds Expectations [Yahoo! Finance]
3/3
03:57 pm
rprx
Royalty Pharma plc (RPRX) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
Neutral
Report
Royalty Pharma plc (RPRX) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
3/3
05:32 am
rprx
Royalty Pharma (RPRX) Achieves Record Growth and Hits Investment Targets Ahead of Schedule [Yahoo! Finance]
Low
Report
Royalty Pharma (RPRX) Achieves Record Growth and Hits Investment Targets Ahead of Schedule [Yahoo! Finance]
3/2
09:15 pm
rprx
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform
Low
Report
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform
3/2
07:35 am
rprx
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform [Yahoo! Finance]
Medium
Report
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform [Yahoo! Finance]
3/2
07:00 am
rprx
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform
Medium
Report
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform
3/2
06:43 am
rprx
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing [Yahoo! Finance]
Medium
Report
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing [Yahoo! Finance]
3/2
06:13 am
rprx
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Medium
Report
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/2
06:10 am
rprx
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
Medium
Report
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
3/1
04:34 am
rprx
TD Cowen Lifts PT on Royalty Pharma Plc (RPRX) to $50 from $45, Here's Why [Yahoo! Finance]
Medium
Report
TD Cowen Lifts PT on Royalty Pharma Plc (RPRX) to $50 from $45, Here's Why [Yahoo! Finance]
2/27
04:14 pm
rprx
Royalty Pharma (RPRX) had its "buy" rating reaffirmed by TD Cowen.
Low
Report
Royalty Pharma (RPRX) had its "buy" rating reaffirmed by TD Cowen.
2/26
04:43 pm
rprx
Royalty Pharma to Present at TD Cowen's 46th Annual Health Care Conference [Yahoo! Finance]
Low
Report
Royalty Pharma to Present at TD Cowen's 46th Annual Health Care Conference [Yahoo! Finance]
2/26
04:15 pm
rprx
Royalty Pharma to Present at TD Cowen’s 46th Annual Health Care Conference
Low
Report
Royalty Pharma to Present at TD Cowen’s 46th Annual Health Care Conference
2/21
09:12 am
rprx
Teva, Medincell granted FDA review for long-acting antipsychotic [Seeking Alpha]
Low
Report
Teva, Medincell granted FDA review for long-acting antipsychotic [Seeking Alpha]